tiprankstipranks
Kala Pharmaceuticals Inc (KALA)
NASDAQ:KALA
Holding KALA?
Track your performance easily

Kala Pharmaceuticals (KALA) Financial Statements

1,446 Followers

Kala Pharmaceuticals Financial Overview

Kala Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-12.472; its P/E ratio is -0.53; Kala Pharmaceuticals is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-2.28. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -8.95M$ -9.58M$ -11.27M$ -7.16M$ -7.25M
EBITDA$ -8.56M$ -9.20M$ -10.89M$ -7.09M$ -7.17M
Net Income Common Stockholders$ -8.95M$ -9.58M$ -11.81M$ -8.63M$ -8.70M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 49.20M$ 54.20M$ 48.48M$ 50.90M$ 56.06M
Total Assets$ 54.08M$ 61.61M$ 53.03M$ 55.95M$ 61.12M
Total Debt$ 37.04M$ 36.80M$ 36.56M$ 36.32M$ 36.08M
Net Debt$ -12.16M$ -17.40M$ -11.92M$ -14.57M$ -19.98M
Total Liabilities$ 47.22M$ 47.89M$ 46.37M$ 48.45M$ 49.90M
Stockholders Equity$ 6.86M$ 13.72M$ 6.66M$ 7.50M$ 11.22M
Cash Flow-
Free Cash Flow$ -4.72M$ -9.21M$ -10.84M$ -7.70M$ -3.23M
Operating Cash Flow$ -4.72M$ -9.21M$ -10.84M$ -7.70M$ -2.95M
Investing Cash Flow$ -90.00K$ -36.00K$ -13.00K$ -7.00K$ 9.72M
Financing Cash Flow$ -180.00K$ 14.97M$ 8.44M$ 2.54M$ 40.00K
Currency in USD

Kala Pharmaceuticals Earnings and Revenue History

Kala Pharmaceuticals Debt to Assets

Kala Pharmaceuticals Cash Flow

Kala Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis